Benefits of repeated FDG PET-CT in the treatment of advanced cervical cancer

被引：0
|
作者：
Burchardt, Ewa [1 ,2 ]
Plachta, Michal [1 ,2 ]
Burchardt, Wojciech [2 ,3 ]
机构：
[1] Greater Poland Canc Ctr, Radiotherapy & Oncol Gynecol, Poznan, Poland
[2] Poznan Univ Med Sci, Dept Electroradiol, Poznan, Poland
[3] Greater Poland Canc Ctr, Brachytherapy Dept, Poznan, Poland
来源：
RADIOTHERAPY AND ONCOLOGY | 2024年 / 194卷
关键词：
cervical cancer; FDG PET-CT; chemotherapy;
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
221
引用
收藏
页码：S976 / S977
页数：2
相关论文
共 50 条
  • [21] Value of FDG-PET/CT for staging of locally advanced cervical cancer
    Barahona, Marc
    Marti, Lola
    Perlaza-Jimenez, Pilar
    Fernandez-Gonzalez, Sergi
    Torrejon, Juan Carlos
    Castilla, Mireia
    Vidal, August
    Najjari-Namal, Dina
    Stefanovic, Milica
    Pardo, Beatriz
    Gil-Martin, Marta
    Ponce, Jordi
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2024, 34 (SUPPL_1) : A8 - A9
  • [22] FDG PET-CT for the Detection of Unknown Primary Cancer
    Moretti, A.
    Nanni, C.
    Galassi, R.
    Fiorentini, G.
    Farsad, M.
    Castellucci, P.
    Rubello, D.
    Zanarini, R.
    Sansovini, M.
    Pandolfi, S.
    Franchi, R.
    Monetti, N.
    Allegri, V.
    Fanti, S.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2005, 32 : S156 - S156
  • [23] Prognostic impact of 18F-FDG PET-CT in patients with locally advanced cervical carcinoma
    Cima, S.
    Galuppi, A.
    De Iaco, P.
    Perrone, M.
    Fanti, S.
    Compagnone, G.
    Valli, M. C.
    Richetti, A.
    Macchia, G.
    Nuzzo, M.
    Deodato, F.
    Ferrandina, G.
    Bertini, F.
    Farioli, A.
    Cammelli, S.
    Frezza, G.
    Morganti, A. G.
    RADIOTHERAPY AND ONCOLOGY, 2016, 119 : S340 - S341
  • [24] FDG PET-CT in locally advanced cervical carcinoma patients (LACC): prognostic impact and clinical management
    Prosperi, D.
    Pacilio, M.
    Carideo, L.
    Di Paolo, A.
    Lauretti, G.
    Pizzichini, P.
    Capriotti, G.
    Tronnolone, L.
    Anzellini, D.
    De Sanctis, V.
    Scopinaro, F.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2018, 45 : S477 - S477
  • [25] CORRELATION BETWEEN BIOLOGICAL MARKER EXPRESSION AND FDG UPTAKE IN CERVICAL CANCER MEASURED BY PET-CT
    Park, S. I.
    Lee, E.
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2014, 24 (09) : 861 - 861
  • [26] Strategy and early results of treatment of advanced cervical cancer patients with synchronous cancers observed in PET-CT imaging
    Plachta, Michal
    Cholewinski, Witold
    Burchardt, Ewa
    Cegla, Paulina
    Urbanski, Bartosz
    Warenczak-Florczak, Zaneta
    Roszak, Andrzej
    GINEKOLOGIA POLSKA, 2017, 88 (09) : 475 - 480
  • [27] Advanced cervical cancer and neoadjuvant treatment: predictive role of 18F-FDG PET/CT for treatment response
    Mapelli, Paola
    Incerti, Elena
    Fallanca, Federico
    Bergamini, Alice
    Dell'Acqua, Andrea
    Rabaiotti, Emanuela
    Petrone, Micaela
    Candiani, Massimo
    Gianolli, Luigi
    Picchio, Maria
    JOURNAL OF NUCLEAR MEDICINE, 2016, 57
  • [28] Neoadjuvant treatment in advanced cervical cancer: can 18F-FDG PET/CT be predictive of response?
    Mapelli, P.
    Fallanca, F.
    Bergamini, A.
    Dell'Acqua, A.
    Mangili, G.
    Rabaiotti, E.
    Incerti, E.
    Candiani, M.
    Gianolli, L.
    Picchio, M.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2015, 42 : S682 - S683
  • [29] 18F-FDG PET-CT in radiation treatment planning for rectal cancer
    Garcia Vicente, A. M.
    Lozano Martin, E.
    Talavera Rubio, M. P.
    Bellon Guardia, M. E.
    Gonzalez Garcia, B.
    Palomar Munoz, A. M.
    Poblete Garcia, V. M.
    Pilkington Woll, J. P.
    Cepedello Boiso, I.
    Cordero Garcia, J. M.
    Perez Romasanta, L. A.
    Soriano Castrejon, A. M.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2009, 36 : S351 - S352
  • [30] Neurolymphomatosis - diagnosis and assessment of treatment response by FDG PET-CT
    Lin, M.
    Kilanowska, J.
    Taper, J.
    Chu, J.
    HEMATOLOGICAL ONCOLOGY, 2008, 26 (01) : 43 - 45
12345